Literature DB >> 14655660

AIDS vaccine fails in Thai trial.

Michael McCarthy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14655660     DOI： 10.1016/S0140-6736(03)14886-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  For protection from HIV-1 infection, more might not be better: a systematic analysis of HIV Gag epitopes of two alleles associated with different outcomes of HIV-1 infection.

Authors:  Ma Luo; Christina A Daniuk; Tamsir O Diallo; Rupert E Capina; Joshua Kimani; Charles Wachihi; Makubo Kimani; Thomas Bielawny; Trevor Peterson; Mark G R Mendoza; Sandra Kiazyk; T Blake Ball; Francis A Plummer
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  A novel approach to inhibit HIV-1 infection and enhance lysis of HIV by a targeted activator of complement.

Authors:  Yuanyong Xu; Chuanfu Zhang; Leili Jia; Cuirong Wen; Huihui Liu; Yong Wang; Yansong Sun; Liuyu Huang; Yusen Zhou; Hongbin Song
Journal:  Virol J       Date:  2009-08-12       Impact factor: 4.099

Review 3.  Autoimmunity and dysmetabolism of human acquired immunodeficiency syndrome.

Authors:  Yan-Mei Huang; Xue-Zhi Hong; Jia-Hua Xu; Jiang-Xi Luo; Han-You Mo; Hai-Lu Zhao
Journal:  Immunol Res       Date:  2016-06       Impact factor: 2.829

4.  PLoS takes a step backward.

Authors:  John J Pippin
Journal:  PLoS Med       Date:  2005-08-30       Impact factor: 11.069

5.  Heterologous protection elicited by candidate monomeric recombinant HIV-1 gp120 vaccine in the absence of cross neutralising antibodies in a macaque model.

Authors:  Mark Page; Richard Stebbings; Neil Berry; Robin Hull; Deborah Ferguson; Leanne Davis; Laura Duffy; William Elsley; Joanna Hall; Claire Ham; Mark Hassall; Bo Li; Edward T Mee; Ruby Quartey-Papafio; Nicola J Rose; Nathalie Mathy; Gerald Voss; E James Stott; Neil Almond
Journal:  Retrovirology       Date:  2012-07-16       Impact factor: 4.602

Review 6.  Traitors of the immune system-enhancing antibodies in HIV infection: their possible implication in HIV vaccine development.

Authors:  Zoltán Beck; Zoltán Prohászka; George Füst
Journal:  Vaccine       Date:  2008-01-10       Impact factor: 3.641

Review 7.  Lessons Learned From Failures and Success Stories of HIV Breakthroughs: Are We Getting Closer to an HIV Cure?

Authors:  V Kalidasan; Kumitaa Theva Das
Journal:  Front Microbiol       Date:  2020-01-31       Impact factor: 5.640

8.  Cytokine Adjuvants IL-7 and IL-15 Improve Humoral Responses of a SHIV LentiDNA Vaccine in Animal Models.

Authors:  Laury-Anne Leroy; Alice Mac Donald; Aditi Kandlur; Deepanwita Bose; Peng Xiao; Jean Gagnon; François Villinger; Yahia Chebloune
Journal:  Vaccines (Basel)       Date:  2022-03-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.